Robin R. Chamberland, PhD D(ABMM)

Saint Louis University School of Medicine
St. Louis, Missouri, United States

Disclosure(s): No financial relationships to disclose

Presentation(s):

• 511 - Activity of Sulbactam-durlobactam and Standard-of-Care Antibiotics against Acinetobacter baumannii-calcoaceticus complex isolates acquired from Hospitalized Patients in the United States (2023 – 2024)

  Saturday, October 19, 2024
  10:54 AM – 11:06 AM US PT